Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference25 articles.
1. Coronavirus infections: more than just the common cold;Paules;JAMA,2020
2. From SARS to MERS, thrusting coronaviruses into the spotlight;Song;Viruses,2019
3. SARS and MERS: recent insights into emerging coronaviruses;de Wit;Nat. Rev. Microbiol.,2016
4. The economic impact of SARS: how does the reality match the predictions?;Keogh-Brown;Health Policy,2008
5. Therapeutic options for the 2019 novel coronavirus (2019-nCoV);Li;Nat. Rev. Drug Discov.,2020
Cited by 292 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19;Journal of Ayurveda and Integrative Medicine;2024-01
2. Novel scaffolds identification against Mpro of SARS-CoV-2 using shape based screening and molecular simulation methods;Chemical Physics Impact;2024-01
3. Research Advances on the Role of Lipids in the Life Cycle of Human Coronaviruses;Microorganisms;2023-12-28
4. Ab initio Modeling of Hydrogen Bonding of Remdesivir and Adenosine with Uridine;ChemPhysChem;2023-12-13
5. Biomimetic nanomaterials for pulmonary infections: A prospective view in drug delivery systems;Applied Nanoscience;2023-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3